Rabenoj-LSR

Rabenoj-LSR Capsules are a dual-action formulation designed to provide effective relief from acid-related disorders and gastrointestinal motility issues. It combines the acid-suppressing effect of Rabeprazole with the prokinetic action of Levosulpiride, ensuring comprehensive management of acidity and digestive discomfort.

Key Benefits

• Provides relief from acidity and heartburn

• Helps manage gastroesophageal reflux disease (GERD)

• Improves gastric motility and digestion

• Reduces bloating, nausea, and discomfort

• Prevents acid reflux and regurgitation

Mechanism of Action

• Rabeprazole (E.C. 20 mg) reduces gastric acid secretion by inhibiting proton pumps, allowing healing of the stomach lining.

• Levosulpiride (S.R. 75 mg) enhances gastrointestinal motility, reducing reflux and improving digestion.

Indications

• GERD (Gastroesophageal Reflux Disease)

• Acid reflux and hyperacidity

• Functional dyspepsia

• Gastritis

• Bloating and delayed gastric emptying

Dosage

• As directed by the physician

• Usually taken once daily before meals

Precautions

• Use under medical supervision

• Avoid long-term use without doctor advice

• May cause dizziness, headache, or gastrointestinal discomfort

• Inform your doctor if you have kidney or liver issues

• Avoid alcohol during treatment

Contraindications

• Hypersensitivity to PPIs or levosulpiride

• Patients with prolactin-dependent tumors

• Use with caution in neurological disorders